Biotech IPO boom has arrived in Europe
2014 was a record year for biotech companies on the European stock market, with a total of €2.4bn raised in the year – 25% more than in the year before.
The European biotech industry experienced a stock market boom in 2014. A total of €2.4bn was poured into biotech companies in Europe via the stock exchange, an increase of 25% compared to the previous year (2013: €1.9bn).
The number of biotech IPOs tripled to 15. A total of 150 biotech companies with a market capitalisation of €66bn are now listed on the 15 most important stock exchanges in Europe.
5 April 2019
The German Market for Health & Care Technologies